There continues to be a debate in the scientific community about the role that angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers play in coronavirus disease 2019 infection.
Simon Murray, MD
Advertisement
Articles by Simon Murray, MD
Hydroxychloroquine and remdesivir have been caught up in the rush to develop an effective treatment for COVID-19.
The state attorney general’s office and its State Board of Medical Examiners are limiting pharmacists and physicians from allowing patients to use certain medications for COVID-19.
An effective treatment plan for squamous cell carcinoma best undertaken by a group of practitioners.
Advertisement
Latest Updated Articles
Pharmacists Can Play an Important Role in Treating Skin CancerPublished: January 8th 2020 | Updated:
New Jersey Restricts Prescribing Medicines Used to Treat COVID-19Published: April 3rd 2020 | Updated:
Clinical Updates on Potential COVID-19 TreatmentsPublished: April 27th 2020 | Updated:
New Evidence Concerning Safety of ACE Inhibitors, ARBs in COVID-19Published: April 28th 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Breaking News: CVS Buys Rite Aid, Bartell Drugs
2
Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer
3
FDA Approves 1-Minute HIV Self-Test
4
Young Women With Symptomatic Long COVID At Higher Risk of POTS
5
